WP 1. Plaque diversity and biomarkers  (patient specific mechanisms)

Asselberghs, S. E. J., Halder, M., Kramann, R., & Sluimer, J. C. (2025). Fibroblasts – the emerging therapeutic target of the cardiovascular system? Pharmacological Reviews, 77(4), 100072. https://doi.org/10.1016/J.PHARMR.2025.100072

Cisternino, F., Song, Y., Peters, T. S., Westerman, R., de Borst, G. J., Diez Benavente, E., van den Dungen, N. A. M., van der Kraak, P. H., De Kleijn, D., Mekke, J. M., Mokry, M., Pasterkamp, G., den Ruijter, H. M., Velema, E., Miller, C. L., Glastonbury, C. A., & van der Laan, S. W. (2025). Intraplaque haemorrhage quantification and molecular characterisation using attention based multiple instance learning. MedRxiv : The Preprint Server for Health Sciences. https://doi.org/10.1101/2025.03.04.25323316

Fahim, N., Sakkers, T. R., Hoekstra, J., de Kleijn, D. P. V., Mokry, M., Verdezoto Mosquera, J., Pasterkamp, G., den Ruijter, H. M., Miller, C. L., van Setten, J., & van der Laan, S. W. (2025a). Genetically determined ancestry associates with morphological and molecular carotid plaque features. MedRxiv : The Preprint Server for Health Sciences. https://doi.org/10.1101/2025.06.07.25329125

Fahim, N., Sakkers, T. R., Hoekstra, J., de Kleijn, D. P. V., Mokry, M., Verdezoto Mosquera, J., Pasterkamp, G., den Ruijter, H. M., Miller, C. L., van Setten, J., & van der Laan, S. W. (2025b). Genetically determined ancestry associates with morphological and molecular carotid plaque features. MedRxiv : The Preprint Server for Health Sciences. https://doi.org/10.1101/2025.06.07.25329125

Ferreira, E. A., Oud, M. M., van der Crabben, S. N., Versloot, M., Goorden, S. M. I., van Karnebeek, C. D. M., Kroon, J., & Langeveld, M. (2025). Inherited Dyslipidemic Splenomegaly: A Genetic Macrophage Storage Disorder Caused by Disruptive Apolipoprotein E (APOE) Variants. Genes, 16(3). https://doi.org/10.3390/GENES16030289

Hanford, K. M. L., Dzobo, K. E., Versloot, M., Peter, J., & Kroon, J. (2025). Protocol to generate a 3D atherogenesis-on-chip model for studying endothelial-macrophage crosstalk in atherogenesis. STAR Protocols, 6(1). https://doi.org/10.1016/j.xpro.2024.103559

Jarr, K. U., Palm, K. C. A., Pasterkamp, G., Mokry, M., & Leeper, N. J. (2025a). Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis. Circulation, 152(3), 208–211. https://doi.org/10.1161/CIRCULATIONAHA.124.072676

Jarr, K. U., Palm, K. C. A., Pasterkamp, G., Mokry, M., & Leeper, N. J. (2025b). Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis. Circulation, 152(3), 208–211. https://doi.org/10.1161/CIRCULATIONAHA.124.072676

Kraaijenhof, J. M., Peletier, M. C., Nurmohamed, N. S., Hovingh, G. K., Alexander, V. J., Tsimikas, S., Stroes, E. S. G., & Kroon, J. (2025). Plasma reduction of apolipoprotein C-III with olezarsen leads to significant reductions in postprandial triglyceride levels: Results from a randomized trial. European Journal of Preventive Cardiology. https://doi.org/10.1093/EURJPC/ZWAF478

Palm, K. C. A., Yin, X., Baig, F., Theofilatos, K., van der Laan, S. W., de Borst, G. J., de Kleijn, D. P. V, Wojta, J., Stojkovic, S., Mayr, M., den Ruijter, H. M., Pasterkamp, G., Diez Benavente, E., & Mokry, M. (2025a). Proteomic profiling reveals a higher presence of glycolytic enzymes in human atherosclerotic lesions with unfavourable histological characteristics. Cardiovascular Research, 121(8). https://doi.org/10.1093/CVR/CVAF077

Palm, K. C. A., Yin, X., Baig, F., Theofilatos, K., van der Laan, S. W., de Borst, G. J., de Kleijn, D. P. V, Wojta, J., Stojkovic, S., Mayr, M., den Ruijter, H. M., Pasterkamp, G., Diez Benavente, E., & Mokry, M. (2025b). Proteomic profiling reveals a higher presence of glycolytic enzymes in human atherosclerotic lesions with unfavourable histological characteristics. Cardiovascular Research, 121(8). https://doi.org/10.1093/CVR/CVAF077

Pasterkamp, G., Den Ruijter, H. M., & Mokry, M. (2025a). Plaque erosion: Unmasking the complexity of atherosclerotic disease. European Heart Journal, 46(23), 2220–2222. https://doi.org/10.1093/EURHEARTJ/EHAF197

Pasterkamp, G., Den Ruijter, H. M., & Mokry, M. (2025b). Plaque erosion: Unmasking the complexity of atherosclerotic disease. European Heart Journal, 46(23), 2220–2222. https://doi.org/10.1093/EURHEARTJ/EHAF197

Slenders, L., Wesseling, M., Wei, S., Boltjes, A., Kapteijn, D. M. C., van de Kraak, P., Depuydt, M. A. C., Prange, K. H. M., van den Dungen, N. A. M., Benavente, E. D., de Kleijn, D. P. V., de Borst, G. J., de Winther, M. P. J., den Ruijter, H. M., Owens, G. K., Pasterkamp, G., & Mokry, M. (2025). Endothelial-to-mesenchymal transition gene signature derived from single-cell transcriptomics of human atherosclerotic tissue associates with stable plaque histological characteristics. Vascular Pharmacology, 159. https://doi.org/10.1016/j.vph.2025.107498

Xu, H., & Sluimer, J. (2025). IL-1β inhibition in stabilizing atherosclerotic plaques: The critical role of fibroblast-like cells. Vascular Pharmacology, 159. https://doi.org/10.1016/j.vph.2025.107493

Yu, B., Sopic, M., & Sluimer, J. C. (2025). Single-cell RNA sequencing (scRNA-seq) and its insights into cellular heterogeneity in atherosclerosis. Vascular Pharmacology, 159. https://doi.org/10.1016/J.VPH.2025.107499

Gurgone, D., Kroon, J., Antoniades, C. (2025). From lipids and inflammation to artificial intelligence-driven therapeutics: the 93rd European atherosclerosis society (EAS) congress 2025 in focus. Cardiovasc Res, 121. https://doi.org/10.1093/cvr/cvaf110

Pasut, A., Lama, E., Van Craenenbroeck, A. H., Kroon, J., Carmeliet, P. (2025). Endothelial cell metabolism in cardiovascular physiology and disease. Nat Rev Cardiol. https://doi.org/10.1038/s41569-025-01162-x

 

WP 2. Fundamental insights in mechanisms driving atherosclerosis diversity

 de Mol, J., Smit, V., Kleijn, M. N. A. B., van Santbrink, P. J., Bot, I., & Foks, A. C. (2025). Immunosenescence accelerates atherosclerosis development in AAV-PCSK9 mouse model. GeroScience. https://doi.org/10.1007/S11357-025-01768-6

Delfos, L., Depuydt, M. A. C., Chemaly, M., Coyle, S., Schaftenaar, F. H., van Santbrink, P. J., Lindenbergh, P. P., Bernabé Kleijn, M. N. A., Costello, C., Power, C. A., Coll, R., Peace, A., Gregory-Ksander, M., Foks, A. C., Kuiper, J., McGilligan, V., & Bot, I. (2025). NLRP3 Inflammasome Inhibition by the Novel Bispecific Antibody InflamAb Attenuates Atherosclerosis in Apolipoprotein E–Deficient Mice. JACC: Basic to Translational Science, 10(6), 826–840. https://doi.org/10.1016/j.jacbts.2024.12.012

Ekkelenkamp, E. D., van Assen, M., van Dijk, J. D., Vendel, B. N., van Dalen, J. A., & Vliegenthart, R. (2025). Protocol optimization and myocardial blood flow quantification in dynamic myocardial perfusion CT—where do we stand? European Radiology, 35(8). https://doi.org/10.1007/S00330-025-11379-6

Groenen, A. G., Matveyenko, A., Matienzo, N., Halmos, B., Zhang, H., Westerterp, M., & Reyes-Soffer, G. (2024). Apolipoprotein(a) production and clearance are associated with plasma IL-6 and IL-18 levels, dependent on ethnicity. Atherosclerosis, 391, 117474. https://doi.org/10.1016/J.ATHEROSCLEROSIS.2024.117474

Halmos, B., La Rose, A. M., Methorst, D., Groenen, A. G., Nakládal, D., Bazioti, V., Koster, M. H., Kloosterhuis, N. J., Buiten, A. Van, Schouten, E. M., Huijkman, N. C. A., Langelaar-Makkinje, M., Bongiovanni, L., De Neck, S. M., De Bruin, A., Buikema, H., Deelman, L. E., Van Den Heuvel, M. C., Kuipers, F., … Westerterp, M. (2025). SMC Abca1 and Abcg1 Deficiency Enhances Urinary Bladder Distension but Not Atherosclerosis. Circulation Research, 136(5), 491–507. https://doi.org/10.1161/CIRCRESAHA.124.325103

Janssen, S. L. J. E., Aengevaeren, V. L., de Vries, F., Kleinnibbelink, G., Mingels, A. M. A., Hopman, M. T. E., Mosterd, A., Velthuis, B. K., Riksen, N. P., & Eijsvogels, T. M. H. (2025a). Exercise-Induce Changes in Hemodynamics, Hormones, Electrolytes and Inflammatory Markers in Veteran Athletes with and without Coronary Atherosclerosis. Medicine and Science in Sports and Exercise, 57(7). https://doi.org/10.1249/MSS.0000000000003674

Janssen, S. L. J. E., Aengevaeren, V. L., de Vries, F., Kleinnibbelink, G., Mingels, A. M. A., Hopman, M. T. E., Mosterd, A., Velthuis, B. K., Riksen, N. P., & Eijsvogels, T. M. H. (2025b). Exercise-Induce Changes in Hemodynamics, Hormones, Electrolytes and Inflammatory Markers in Veteran Athletes with and without Coronary Atherosclerosis. Medicine and Science in Sports and Exercise, 57(7). https://doi.org/10.1249/MSS.0000000000003674

Kessler, E. L., Dal Canto, E., Diez-Benavente, E., van Ommen, A. M., Kapteijn, D., Glade, M. C., Bekkering, S., Haitjema, S., Valstar, G., Cramer, M. J., Rutten, F. H., Teske, A. J., Menken, R., Hofstra, L., den Ruijter, H. M., Riksen, N. P., & de Jager, S. C. A. (2025). Non-classical monocytes are associated with functional markers of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction. International Journal of Cardiology, 429. https://doi.org/10.1016/j.ijcard.2025.133161

Scarpa, A., Jung, Y., Hamid, A., Matzaraki, V., More, T., Heinz, A., Groh, L., Bekkering, S., Hiller, K., Joosten, L. A. B., Netea, M. G., Placek, K., & Riksen, N. P. (2025). Trained Immunity Induced by Oxidized Low-Density Lipoprotein Is Dependent on Glutaminolysis. FASEB Journal, 39(13). https://doi.org/10.1096/FJ.202500802R

 

WP3. Cohorts and translation 

Pavlović, J., Bos, D., Ikram, M. K., Ikram, M. A., Kavousi, M., & Leening, M. J. G. (2025). Guideline-Directed Application of Coronary Artery Calcium Scores for Primary Prevention of Atherosclerotic Cardiovascular Disease. JACC: Cardiovascular Imaging, 18(4), 465–475. https://doi.org/10.1016/j.jcmg.2024.12.008

Reilly, N. A., Dekkers, K. F., Molenaar, J., Arumugam, S., Kuipers, T. B., Ariyurek, Y., Hoeksema, M. A., Jukema, J. W., & Heijmans, B. T. (2025). EPA Induces an Anti-Inflammatory Transcriptome in T Cells, Implicating a Triglyceride-Independent Pathway in Cardiovascular Risk Reduction. JACC: Basic to Translational Science, 10(3), 383–395. https://doi.org/10.1016/j.jacbts.2024.09.002

WP4. Imaging diversity (in interventions)

Berge, K., Janssen, S. L. J. E., Velthuis, B. K., Myhre, P. L., Mosterd, A., Omland, T., Eijsvogels, T. M. H., & Aengevaeren, V. L. (2025). Predictors of coronary atherosclerosis in middle-aged and older athletes: the MARC-2 study. European Heart Journal Cardiovascular Imaging, 26(3), 461–470. https://doi.org/10.1093/EHJCI/JEAE317

Dahdal, J., Jukema, R. A., Maaniitty, T., Nurmohamed, N. S., Raijmakers, P. G., Hoek, R., Driessen, R. S., Twisk, J. W. R., Bär, S., Planken, R. N., van Royen, N., Nijveldt, R., Bax, J. J., Saraste, A., van Rosendael, A. R., Knaapen, P., Knuuti, J., & Danad, I. (2025). CCTA-Derived coronary plaque burden offers enhanced prognostic value over CAC scoring in suspected CAD patients. European Heart Journal Cardiovascular Imaging, 26(6), 945–954. https://doi.org/10.1093/EHJCI/JEAF093

Fiolet, A. T. L., Lin, A., Kwiecinski, J., Tutein Nolthenius, J., Mcelhinney, P., Grodecki, K., Kietselaer, B., Opstal, T. S., Cornel, J. H., Knol, R. J. J., Schaap, J., Aarts, R. A. H. M., Tutein Nolthenius, A. M. F. A., Nidorf, S. M., Velthuis, B. K., Dey, D., & Mosterd, A. (2025). Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trial. Heart. https://doi.org/10.1136/HEARTJNL-2024-325527

Guglielmo, M., Coraducci, F., & Pavon, A. G. (2025). When coronary plaque is found in everyone: is anyone really at risk? European Heart Journal – Cardiovascular Imaging, 26(7). https://doi.org/10.1093/EHJCI/JEAF137

Janssen, S. L. J. E., van Everdingen, W. M., Saalmink, W. B. J., Lamers, S. K., Vroemen, W. H. M., Denessen, E. J. S., Berge, K., Bekers, O., Hopman, M. T. E., Brink, M., Habets, J., Aengevaeren, V. L., Mingels, A. M. A., Nijveldt, R., Eijsvogels, T. M. H., Aaldering, A., Bambacht, R. C. B., Bongers, C. C. W., Brouwer, C. G., … Vermeulen, J. J. M. (2025). Relationship Between Exercise-Induced Cardiac Troponin Elevations and Occult Coronary Atherosclerosis in Middle-Aged Athletes. Journal of the American College of Cardiology, 85(24), 2370–2382. https://doi.org/10.1016/J.JACC.2025.04.047

Klevmoen, M., Mulder, J. W. C. M., Bogsrud, M. P., Retterstøl, K., Vesterbekkmo, E. K., Pedersen, E. K. R., Freiberger, T., Vrablik, M., Vaclova, M., Hovland, A., Vethe, N. T., Brekke, H. K., Iversen, P. O., Veierød, M., Roeters van Lennep, J., & Holven, K. B. (2025). Prospective study on breastfeeding, lipid profile and cardiovascular risk markers in women with familial hypercholesterolaemia: study protocol for the FH-FEMINA study. BMJ Open, 15(4), e092208. https://doi.org/10.1136/BMJOPEN-2024-092208

Mijnster, R. J. M., Mulder, J. W. C. M., Galema-Boers, A. M. H., Mattace-Raso, F., Muller, M., Lafeber, M., & Roeters van Lennep, J. E. (2025). Efficacy and safety of PCSK9 monoclonal antibodies in older patients: A real-world registry. Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2025.120229

Mulder, J. W. C. M., Galema-Boers, A. M. H., Kranenburg, L. W., Redekop, K., & Roeters van Lennep, J. E. (2025). PCSK9 inhibitor experiences and preferences of patients and healthcare professionals in decision-making: A mixed methods study. Atherosclerosis, 401. https://doi.org/10.1016/j.atherosclerosis.2024.119101

Mulder, J. W. C. M., Reijman, M. D., Kusters, D. M., Boersma, E., Alnouri, F., Blom, D. J., Catapano, A. L., Cuchel, M., Dann, E. J., Freiberger, T., Groselj, U., Harada-Shiba, M., Hovingh, G. K., Iatan, I., Ibarretxe, D., Kayikcioglu, M., Kim, N. T., Klingel, R., Raal, F. J., … Wang, L. (2025). Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition: Medical Life-Trajectories in the Post-2010 Era. Journal of the American College of Cardiology, 85(19), 1898–1903. https://doi.org/10.1016/j.jacc.2025.04.005

Mulder, J. W. C. M., Schonck, W. A. M., Tromp, T. R., Reijman, M. D., Reeskamp, L. F., Hovingh, G. K., Blom, D. J., & Roeters van Lennep, J. E. (2025). Real-world family planning and pregnancy practices in women with homozygous familial hypercholesterolemia. Atherosclerosis, 404. https://doi.org/10.1016/j.atherosclerosis.2025.119187

Roeters van Lennep, J. E., Öörni, K., Binder, C. J., Kronenberg, F., Mallat, Z., Raggi, P., Benn, M., Afzal, S., Holven, K. B., Kayikcioglu, M., Laufs, U., Liberopoulos, E., Ray, K. K., Nordestgaard, B. G., & Boren, J. (2025). The essential role of sex and gender in atherosclerosis research: A statement from the Editorial Board of Atherosclerosis and Executive Committee of the European Atherosclerosis Society. Atherosclerosis, 407, 120403. https://doi.org/10.1016/j.atherosclerosis.2025.120403

Roeters van Lennep, J., Saleh, L., & Verdonk, K. (2025). Adverse pregnancy outcomes: A First Warning, Not a Fate. Shifting the Focus from cardiovascular risk to cardiovascular Health. European Journal of Preventive Cardiology. https://doi.org/10.1093/EURJPC/ZWAF231

van der Bijl, M. F., van der Veen, J., Fiolet, A. T. L., Boersma, E., Cornel, J. H., Eikelboom, J. W., Nidorf, S. M., Thompson, P. L., Jannink, J., Westendorp, I. C. D., Mosterd, A., Den Den Ruijter, H. M., & Roeters van Lennep, J. E. (2025). Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial. Journal of the American Heart Association , 14(5). https://doi.org/10.1161/JAHA.124.040412

Van Leuven, S. I., Van Bon, L., Nijveldt, R., & Major, A. S. (2025). Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion. Rheumatology Advances in Practice, 9(2). https://doi.org/10.1093/RAP/RKAF048

van Oortmerssen, J. A. E., Mulder, J. W. C. M., Kavousi, M., & Roeters van Lennep, J. E. (2025). Lipid metabolism in women: A review. Atherosclerosis, 405. https://doi.org/10.1016/j.atherosclerosis.2025.119213

van Oortmerssen, J. A. E., Mulder, J. W. C. M., van der Bijl, M. F., Mijnster, R. J. M., Kavousi, M., & Roeters van Lennep, J. E. (2025). Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women. Current Atherosclerosis Reports, 27(1). https://doi.org/10.1007/S11883-025-01275-1

 

Other 

Marques- Antunes, M., van Oort, M. J. H., Oliveri, F., Al Amri, I., Bingen, B. O., Cruz-Ferreira, R., Wouter Jukema, J., & Montero-Cabezas, J. M. (2025). Angiographic Characterization and Sex-Related Anatomical Differences of Atrial Coronary Arteries Anatomy—A Proposal of Systematic Classification. Catheterization and Cardiovascular Interventions, 105(4), 951–958. https://doi.org/10.1002/CCD.31414

Oliveri, F., García, P. V., van Oort, M. J. H., Phagu, A., Al Amri, I., Bingen, B. O., Paradies, V., Mincione, G., Claessen, B. E., Dimitriu-Leen, A. C., Kefer, J., Girgis, H., Vossenberg, T., Mandurino-Mirizzi, A., Van der Kley, F., Jukema, J. W., & Montero-Cabezas, J. M. (2025). Intravascular lithotripsy for the treatment of calcified coronary lesions in individuals of advanced age: a post-hoc analysis of the multicentre, prospective BENELUX-IVL study. EClinicalMedicine, 85. https://doi.org/10.1016/J.ECLINM.2025.103342

Oliveri, F., Merino, I., van Oort, M. J. H., Al Amri, I., Bingen, B. O., Arslan, F., Claessen, B. E., Dimitriu-Leen, A. C., Kefer, J., Girgis, H., Vossenberg, T., van der Kley, F., Jukema, J. W., & Montero-Cabezas, J. (2025). Intravascular lithotripsy and temporary mechanical circulatory support for the treatment of heavily calcified coronary artery disease: insights from the BENELUX-IVL registry. Heart and Lung, 73, 108–113. https://doi.org/10.1016/j.hrtlng.2025.04.030

Oliveri, F., Van Oort, M. J. H., Al Amri, I., Bingen, B. O., Claessen, B. E., Dimitriu-Leen, A. C., Kefer, J., Girgis, H., Vossenberg, T., Van der Kley, F., Jukema, J. W., & Montero-Cabezas, J. M. (2025). Coronary Compliance Modification by Intravascular Lithotripsy: New Predictor of Stent Expansion in Calcified Coronary Lesions. Journal of the Society for Cardiovascular Angiography and Interventions, 4(5). https://doi.org/10.1016/J.JSCAI.2025.102635

Oliveri, F., van Oort, M. J. H., Al Amri, I., Bingen, B. O., Claessen, B. E., Dimitriu-Leen, A. C., Kefer, J., Girgis, H., Vossenberg, T., van der Van der Kley, F., Jukema, J. W., & Montero-Cabezas, J. M. (2025). Intravascular Lithotripsy in Acute Coronary Syndromes: Procedural and One-Year Clinical Outcomes From the BENELUX-IVL Registry. Catheterization and Cardiovascular Interventions, 105(2), 385–393. https://doi.org/10.1002/CCD.31307

Oliveri, F., van Oort, M. J. H., Phagu, A. A. S., Al Amri, I., Bingen, B. O., Claessen, B. E. P. M., Dimitriu-Leen, A. C., Kefer, J., Girgis, H., Vossenberg, T., Van der Kley, F., Jukema, J. W., & Montero-Cabezas, J. M. (2025). Intravascular lithotripsy in calcified left main coronary artery: Procedural success and 1-year clinical outcomes. International Journal of Cardiology, 423. https://doi.org/10.1016/j.ijcard.2025.132996

Oliveri, F., Van Oort, M., Van der Kley, F., Jukema, J. W., & Montero-Cabezas, J. (2025). Dual Sinus Origins of the Left Coronary Artery From the Right and Left Coronary Sinus. CJC Open, 7(7). https://doi.org/10.1016/j.cjco.2025.04.015

Polomski, E. A. S., Heemelaar, J. C., de Ronde, M. E. S., Al Jaff, A. A. M., Mertens, B. J. A., van Dijkman, P. R. M., Jukema, J. W., & Antoni, M. L. (2025). Increased prevalence of coronary atherosclerosis in cancer survivors: A retrospective matched cross-sectional study with coronary CT angiography. American Heart Journal, 282, 134–145. https://doi.org/10.1016/j.ahj.2025.01.004

van Oort, M. J. H., Bingen, B. O., Oliveri, F., Al Amri, I., Phagu, A. A. S., Claessen, B. E. P. M., Dimitriu-Leen, A. C., Vossenberg, T. N., Kefer, J., Girgis, H., van der Kley, F., Jukema, J. W., & Montero-Cabezas, J. M. (2025). Clinical and Technical Predictors of Treatment Success After Coronary Intravascular Lithotripsy in Calcific Coronary Lesions. Catheterization and Cardiovascular Interventions, 105(6), 1418–1426. https://doi.org/10.1002/CCD.31480

van Oort, M. J. H., Oliveri, F., Amri, I. Al, Bingen, B. O., Claessen, B. E. P. M., Dimitriu-Leen, A. C., Vossenberg, T. N., Kefer, J., Girgis, H., van der Kley, F., Jukema, J. W., & Montero-Cabezas, J. M. (2025). Sex Differences in a Real-World Registry Examining Coronary Lithotripsy for Calcified Lesions. American Journal of Cardiology, 236, 49–55. https://doi.org/10.1016/J.AMJCARD.2024.11.002